In a recent report, Finlay, Hobby, and their collaborators1 have described a new crystalline antibiotic, terramycin, isolated from broth cultures of a new actinomycete, Streptomnyces rimosus. In vitro studies8 of terramycin and its salts have shown that this antibiotic in low concentrations is a highly effective bacteriostatic agent against a wide variety of gram-positive and gram-negative bacteria. In vivo observations8 have also shown that it is a highly effective therapeutic agent against experimental animal infections with terramycin-sensitive organisms. It possesses low toxicity.1'8 Studies' on absorption and excretion in dogs and rabbits have shown that terramycin salts are absorbed readily following either oral or parenteral administration, the most satisfactory results having been obtained on oral administration of the hydrochloride. It would appear from the foregoing experimental data that terramycin should be an effective antibiotic agent for the treatment of a variety of infections in man.3" A therapeutic evaluation has, therefore, been undertaken,8 in which we have had the opportunity to participate.
The present report records our clinical experience to date with the use of terramycin in fifteen patients with various infections. Methods Selection of patients. The patients selected for treatment were arbitrarily chosen to represent a considerable variety of infections, in some of whom other chemotherapeutic agents had been ineffective. Dosage. Terramycin hydrochloride administered orally was used in all cases. An initial or loading dose of 1.0 gm. q.h. for three doses was given in 10 patients, of 1.0 gm. in 5 patients. Subsequent treatment varied from 3.0 to 6.0 gm. per day given in 0.5 gm. or 0.75 gm. doses q.3 h. or q.4 h. depending on the nature of the illness and response to treatment. In seven instances the dosage was reduced to 0.25 gm. q. 
Case reports
The patients selected for treatment with terramycin were 1 case of acute staphylococcal endocarditis, 2 of subacute streptococcal endocarditis, 4 1950, severely ill and semicomatose, on the ninth day of disease, after having failed to respond to intermittent treatment with sulfadiazine and penicillin at home. Having further failed to respond to 1,050,000 units of penicillin, terramycin therapy was instituted on the 11th day of illness and continued for 53 days. Progressive gradual improvement ensued. The temperature became normal on the 12th day of treatment, no further embolic phenomena occurred, and the hemiplegia gradually disappeared except for residual weakness of the left foot. Although the staphylococcemia promptly abated under terramycin therapy, it should be noted that blood cultures were occasionally positive for Staphylococcus aureus during the first four weeks of treatment and became permanently negative only after the dose of terramycin had been increased to 6.0 gnL per day for a week. Whether the increase in dosage or the evenitual healing of the CHART 2. Case W.P. Subacute bacterial endocarditis due to Streptococcus fecalis. mitral endocarditis was responsible for this is uncertain. At the time of discharge on the 59th hospital day, recovery was apparently complete except for a persistent apical systolic murmur and weakness of the left foot.
Case W.P., age 70, male. Chart 2. Subacute bacterial endocarditis due to Streptococcus fecalis, the growth of which was inhibited by 2.0 jug./cc. of terramycin but not by 10 usg./cc. of chloromycetin, 100 jg./cc. of streptomycin nor 5 un./cc. of penicillin.
This patient, admitted on February 2, 1950, approximately one month after the onset of his illness, was started on terramycin therapy on March 15, after the diagnosis had been established by the appearance of an apical systolic murmur, a palpable spleen, scattered sparse petechiae, and repeatedly positive blood cultures. As shown in Chart 2, the original dosage of 4.0 gm. per day was probably inadequate. On the 11th day of AOO treatment the dose was increased to 6.0 gin. per day, being maintained at this level for 19 days. As a result, the temperature returned to normal and repeated blood cultures remained sterile. On the 30th day of treatment, because of anorexia, nausea, and occasional vomiting, the dose was reduced to 4.0 gm. per day and was maintained at that level until the 47th day, when treatment was discontinued. Beginning six days later, however, blood cultures again became positive for Streptococcus fecalis, and it was apparent that the infection had not been cured.
Case E.F., age 62, male. Chart 3. Subacute bacterial endocarditis due to Streptococcus *iridans, the growth of which was inhibited by 1 approximately six months with a chronic cystitis which had failed to respond to sulfadiazine, penicillin, and streptomycin. Two weeks before admission she had developed an acute exacerbation. Cultures of the urine showed it to be heavily infected with B. mucosus capsulatus, which was found to be sensitive to 5.0 Ag./cc. of terramycin, to < 25.0 > 5.0 gg./cc. of streptomycin. After an initial dose of 1.0 gm. of terramycin, she was treated with 0.4 gm. q.4 h. for 4 days followed by 0.25 gm. q.4 h. for 2 days. The symptoms of cystitis rapidly subsided. Urine cultures were sterile on the 3rd day and remained so until discharge on the 11th day.
Case J.G., age 46, male. Urinary tract infection with B. inucosus capsulatuts. This patient, severely ill with hypertensive cardiovascular disease, diabetes mellitus, and nephritis with azotemia, had had symptoms of cystitis for approximately one month.
On admission, cultures of the urine showed a heavy growth of B. nmucosus capsulatus, which was found to be sensitive to 4.0 Ag./cc. of terramycin. After 4 days of penicillin therapy without effect, he was treated with terramycin-initial dose 1.0 gm., then 0.5 gm. q.4 h. for 10 days. During the period of treatment there was considerable reduction in the albuminuria, pyuria, hematuria, and bacilluria, but the infection was not eliminated. Nausea and vomiting became quite troublesome, and the N.P.N. rose from 85 mg.%o to 117 mg.%o. It seemed possible under these conditions that the excretion of terramycin in the urine might be inadequate to exert a bacteriostatic effect. Consequently, on the 9th day of treatment, the concentration of terramycin was determined in 4 samples of urine collected at 4:00, 5:00, 7:00, and 8:00 p.m., 0.5 gm. of terramycin having been given at 4:00 p.m. In all 4 samples the concentration was found to be 32 ,g./cc., a considerably smaller amount than would be expected with normally functioning kidneys,' but still 8 times the concentration required to inhibit the growth of the patient's strain of B. mucosus capsulatus. Subsequent treatment with streptomycin also failed to eliminate the urinary tract infection in this patient. Case A.P., age 56, female. Staphylococcal pyoderma. This patient with a diffuse, exfoliative dermatitis covering her face, trunk, and extremities, developed a severe bullous pyoderma of her fingers, palms, feet, and left lower leg and was admitted at once. By the 4th day she was critically ill with spreading pyoderma and a temperature of 102.80 F. Cultures of pus withdrawn from an unruptured bulla showed a heavy growth of Staphylococcus aureus and a moderate growth of Staphylococcus albus. Blood culture was negative. The Staph. aureus was sensitive to 1.0 jg./cc. of terramycin, the Staph. albus to 0.5 sg./cc. Treatment with terranycin was initiated on r3 I ar, a.oj ,Mw% 1c 504 the 4th day with 1.0 gm. q.h. 3x, followed by 0.5 gm. q.3 h. for 7 days and 0.25 gm. q.4 h. for 1 day. The temperature fell rapidly and reached normal within a week; the pyoderma subsided progressively and had disappeared by the 3rd day of treatment.
Case J.A., age 27, male. Buccal and penile fusospirochetosis. This patient, admitted on the 7th day of illness, presented the picture of a severe ulcerative Vincent's infection of the whole buccal mucosa and the glans penis, superimposed upon a preceding vesiculopapular eruption which involved the skin of the face, arms, and trunk, and the buccal mucous membranes. Smears from the gums and glans penis showed innumerable fusiform bacilli and Vincent's spirochetes. After 3 days without improvement he was treated with terramycin as follows: initial dose 1.0 gm. q.h. 3x, 0.5 gm. q.3 h. for 4 days, 0.25 gm. q.4 h. for 1 day. Within 24 hours fusiform bacilli and spirochetes were no longer demonstrable in smears from the gums and only a few spirochetes were seen in the smear from the glans penis. The lesions of the buccal mucosa and glans penis subsided rapidly and were healed by the 6th day of treatment.
Case R.S., age 53, male. Influenza. Admitted on the 4th day of disease, acutely ill, temperature 103.40 F. Terramycin, initial dose 1.0 gm. q.h. 3x, followed by 4.0 gm. per day for 2¼2 days had no apparent effect on the course of the disease.
Case G.G., age 36, male. Chart 6. Cholangeitis lenta. This patient was admitted on April 1, 1950, with a history of chills, fever, and general malaise for 8 days, which developed suddenly 9 days after a transient attack of mid-abdominal pain. Physical examination revealed only a slight icterus. As shown in Chart 6, he continued to run a high fever, and on 2 occasions blood cultures were positive for Streptococcus siridans. The diagnosis of cholangeitis lenta was finally established by a liver puncture biopsy which showed diffuse cholangeitis and pericholangeitis. Cultures of the liver tissue were positive for Streptococcus viridans similar to that obtained in blood cultures and also showed a non-hemolytic gamma streptococcus. The Streptococcus viridans was sensitive to 2.0 /Lg./cc. of terramycin. Terramycin therapy was instituted on the 22nd day with an initial dose of 1.0 gm. q.h. 3x, followed by 6.0 gm. per day for 8¼2 days. It was then reduced to 3.0 gm. per day for 4¼2 days. Within 96 hours the patient had shown marked improvement and the jaundice was diminishing rapidly.
He appeared fully recovered by the 7th day of treatment, and further convalescence was uneventful.
Discussion
The number of cases described in this preliminary report is too limited and the variety of clinical material too great to warrant more than tentative suggestions concerning some of the infections in which terramycin should prove to be an effective antibiotic agent. Among these are pneumococcal lobar pneumonia; staphylococcal infections, both focal and generalized; alpha hemolytic streptococcal infections, including both S. viridans and S. fecalis; urinary tract infections with gram-negative bacilli, including some strains at least of E. coli, B. mucosus capsulatus, and B. proteus; and 505 YALE JOURNAL OF BIOLOGY AND MEDICINE Vincent's fusospirochetosis. The apparent cure of Case E.S. with staphylococcal endocarditis, of Case G.G. with severe diffuse intrahepatic cholangeitis, and the prompt recovery of three cases of lobar pneumonia treated early in the disease lend strong support to these suggestions.
In the two cases of subacute bacterial endocarditis the response to terramycin appeared to be essentially the same as might have been expected with adequate doses of penicillin for an equivalent length of time. Shortly after terramycin was stopped, however, relapse occurred in both cases. Whether more prolonged treatment would have been successful is uncertain at present.
The four cases of urinary tract infection were selected to determine whether infections which had not yielded to other chemotherapeutic and antibiotic agents would respond to terramycin. While this occurred promptly in three of the four cases, it is of course likely that reinfection of the urinary tract in these cases will recur, and in fact it had done so in one case (E.S.) within a week after treatment had been discontinued.
The dosage employed was somewhat arbitrary and may have been more than necessary in some cases, particularly with respect to the initial or loading dose. There is a suggestion, at least, that a single dose of 1.0 gm. instead of three doses at hourly intervals would often be sufficient. Much further study will be required to define the most appropriate dosage for various infections. Equally uncertain at present is the minimum duration of treatment that will be effective in preventing relapse.
The only untoward side effects observed were nausea, vomiting, and frequent loose stools. As will be seen from Table 1 , 7 cases had no nausea or vomiting, 10 cases no vomiting, and 6 cases no frequency of stools. In only 2 cases (W.P. when receiving 6.0 gm. daily and J.G. with nephritis and azotemia) were nausea and vomiting troublesome. In 7 of the 8 cases with loose frequent stools, this phenomenon occurred for 2 to 3 days with 2 to 4 stools per day. In only 1 case (C.S. with perineal fistula) was it troublesome or persistent.
Summary
The results of terramycin therapy in 15 patients with various infections have been described. The response to therapy in 12 was sufficiently prompt and clear cut to warrant the suggestion that terramycin will prove to be a valuable antibiotic agent for the treatment of a considerable variety of human infections caused by terramycin-sensitive microorganisms.
